Rheumatic fever epidemiology and demographics
|
Rheumatic fever Microchapters |
|
Epidemiology and Demographics |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Rheumatic fever epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Rheumatic fever epidemiology and demographics |
|
Blogs on Rheumatic fever epidemiology and demographics</small> |
|
Risk calculators and risk factors for Rheumatic fever epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Lance Christiansen, D.O.; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Varun Kumar, M.B.B.S. [3]
Overview
Rheumatic fever, and therefore Streptococus pyogenes infections, are endemic in many developing countries. In countries affected by the industrial revolution, domestic living conditons became less crowded, due to the development of larger homes and families had fewer children. In addition, living conditions became, generally, more hygienic. The introduction of antibiotics, first sulfonamide in the early 1930's and then penicillin in the 1940's, further caused Streptococcus pyogenes infections to become less common and less severe in economically developed countries although they never disappeared.
Developed Countries
The incidence of rheumatic fever in developed nations is low, likely due to improved hygienic standards and routine use of antibiotics for acute pharyngitis[1]. The incidence and prevalence of rheumatic fever in countries like the USA and Canada were approximately 20-40/100,000 persons during the period 1970-1990 with rheumatic heard disease (RHD) occurring sporadically. Over past two decades, the prevalence of rheumatic fever has decreased to 5-20/100,000 persons in Canada and < 5/100,000 persons in the USA with no new cases of rheumatic heart disease[2]. However, the incidence and prevalence of rheumatic fever and rheumatic heart disease has increase to > 100/100,000 persons and 4-10/1,000 persons respectively in Australia.
Developing Countries
The rates of rheumatic fever and rheumatic heart diseases among developing nations have mixed trends. According to recent a recent worldwide report, the incidence rates of rheumatic fever has decreased in India, China and african countries mainly attributed to improved access to medical treatment. This has led to improved survival rates even among people with rheumatic heart disease and there by increase in prevalence rates have been observed[2]. Newer studies relying on echocardiography in the diagnosis of RHD have demonstrated that rates of subclinical carditis is up to 10 times higher than that diagnosed by clinical examination[3][4][5][6]. India, Pakistan, Russia, Mediterranean and African countries have high prevalence rates of RHD. It is estimated that approximately there are 62-78 million RHD patients worldwide which could potentially result in 1.4 million deaths per year[7][8]. Occurrence of rheumatic fever is associated with low socioeconomic and over crowded conditions.
Impact of Age
Rheumatic fever is commonly reported among age group of 5-15years[9]. Group A beta hemolytic streptococcus pharyngitis is uncommon in children less than 3 years of age, and rheumatic fever is extremely rare. Rheumatic fever among adults is less frequent and accounts for 20% of cases.
Impact of Gender
No predilection towards either gender exists. However, certain manifestations of rheumatic fever such as mitral valve prolapse (carditis) and Sydenham chorea are most often observed among females than males[10].
References
- ↑ Miyake CY, Gauvreau K, Tani LY, Sundel RP, Newburger JW (2007). "Characteristics of children discharged from hospitals in the United States in 2000 with the diagnosis of acute rheumatic fever.". Pediatrics 120 (3): 503-8. doi:10.1542/peds.2006-3606. PMID 17766522.
- ↑ 2.0 2.1 Seckeler MD, Hoke TR (2011). "The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease.". Clin Epidemiol 3: 67-84. doi:10.2147/CLEP.S12977. PMID 21386976.
- ↑ Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Jani D et al. (2007). "Prevalence of rheumatic heart disease detected by echocardiographic screening.". N Engl J Med 357 (5): 470-6. doi:10.1056/NEJMoa065085. PMID 17671255.
- ↑ Bhaya M, Panwar S, Beniwal R, Panwar RB (2010). "High prevalence of rheumatic heart disease detected by echocardiography in school children.". Echocardiography 27 (4): 448-53. doi:10.1111/j.1540-8175.2009.01055.x. PMID 20345448.
- ↑ Sadiq M, Islam K, Abid R, Latif F, Rehman AU, Waheed A et al. (2009). "Prevalence of rheumatic heart disease in school children of urban Lahore.". Heart 95 (5): 353-7. doi:10.1136/hrt.2008.143982. PMID 18952636.
- ↑ Carapetis JR, Hardy M, Fakakovikaetau T, Taib R, Wilkinson L, Penny DJ et al. (2008). "Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren.". Nat Clin Pract Cardiovasc Med 5 (7): 411-7. doi:10.1038/ncpcardio1185. PMID 18398402.
- ↑ Paar JA, Berrios NM, Rose JD, Cáceres M, Peña R, Pérez W et al. (2010). "Prevalence of rheumatic heart disease in children and young adults in Nicaragua.". Am J Cardiol 105 (12): 1809-14. doi:10.1016/j.amjcard.2010.01.364. PMID 20538135.
- ↑ Carapetis JR, Steer AC, Mulholland EK, Weber M (2005). "The global burden of group A streptococcal diseases.". Lancet Infect Dis 5 (11): 685-94. doi:10.1016/S1473-3099(05)70267-X. PMID 16253886.
- ↑ Grover A, Dhawan A, Iyengar SD, Anand IS, Wahi PL, Ganguly NK (1993). "Epidemiology of rheumatic fever and rheumatic heart disease in a rural community in northern India.". Bull World Health Organ 71 (1): 59-66. PMID 8440039.
- ↑ Bisno AL. Rheumatic fever. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 313
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
